Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Vertex Pharmaceuticals Inc. buy Oppenheimer Holdings Inc.

Start price
€435.75
30.10.24 / 50%
Target price
€497.12
30.10.25
Performance (%)
-16.92%
End price
€362.00
31.10.25
Summary
This prediction ended on 31.10.25 with a price of €362.00. The price of Vertex Pharmaceuticals Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -16.92%. Oppenheimer_Holdings has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Vertex Pharmaceuticals Inc. -1.509% -1.509% -13.165%
iShares Core DAX® 0.734% -0.964% 17.910%
iShares Nasdaq 100 -2.686% -2.409% 4.267%
iShares Nikkei 225® -2.261% -4.038% 10.420%
iShares S&P 500 -1.346% -1.510% 1.615%

Comments by Oppenheimer_Holdings for this prediction

In the thread Trading Vertex Pharmaceuticals Inc.
Prediction Buy
Perf. (%) -16.92%
Target price 497.124
Change
Ends at 30.10.25

Die von Oppenheimer_Holdings gewählte maximale Laufzeit wurde überschritten

In the thread Vertex Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) -16.92%
Target price 497.124
Change
Ends at 30.10.25

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $550.00 to $540.00. They now have an "outperform" rating on the stock.
Ratings data for VRTX provided by MarketBeat

Stopped prediction by Oppenheimer_Holdings for Vertex Pharmaceuticals Inc.

buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€437.10
05.08.24
€501.77
05.08.25
-25.81%
06.08.25

buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€327.35
02.08.23
€374.74
02.08.24
35.94%
03.08.24